FDA Documents Confirm Pfizer’s 2021 mRNA Vaccine Lots Had Different Formulations Based on Lot#
FDA documents confirm different Pfizer EUA mRNA formulations were injected into over a hundred million Americans. US government patent shows many more mRNA bioweapon formulations
When the emergency use (EUA) COVID-19 mRNA vaccines were first rolled out in the United States, many Americans questioned if different formulations were being distributed. Why? Because some people became severely injured or died after vaccination, while others seemed completely fine. Furthermore, some vaccine lots had higher incidences of severe injuries and deaths, while other lots and little to no adverse events per the VAERS database.
In a court of law, it would be difficult to argue that the incidence of adverse events by lot number is evidence that the EUA mRNA vaccines varied in formulation. One could simply counter argue that people respond differently to biologics and drugs. The varying rates of adverse events can easily be dismissed as a coincidence or potentially attributed to some other factor affecting residents in that region, such as higher rates of obesity.
What one can’t argue against is Pfizer’s and the FDA’s (CBER) own admission that Pfizer’s EUA mRNA vaccines vary in formulations.
Per the FDA’s approval of Pfizer’s Biological License Application (BLA); Dr. Ramachandra Naik, of the FDA/CBER, specifically asked Pfizer, “What EUA mRNA vaccine lots are the same as the FDA approved formulation of COMIRNATY?”
Pfizer’s answer should have been, ‘All of them.’ Why? Because in 2021 the American people were told that there was only one formulation for Pfizer’s EUA COVID-19 mRNA vaccines. But that wasn’t Pfizer’s response. Not even close.
Instead, Pfizer responded to Dr. Naik and the FDA by saying, “Here’s a list of lot numbers for EUA mRNA vaccines that are the same formulation as COMIRNATY.”
This means that throughout 2021, there were some Pfizer EUA mRNA lots that had the same formulation as COMIRNATY and a whole bunch of lots that had different mRNA formulations.
Pfizer’s and the FDA’s own BLA document confirms that Pfizer unleashed multiple COVID-19 mRNA formulations on the American people and our children.
On December 11, 2020, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), assured the American people that, “…the available safety and effectiveness data support the authorization of the Pfizer-BioNTech COVID-19 Vaccine because the vaccine’s known and potential benefits clearly outweigh its known and potential risks.”
My key issue with Dr. Peter Marks’ statement is that he does not clarify which Pfizer COVID-19 mRNA formulation he claims to know the risks outweigh the benefit for.
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.